The latest updates from AFAR.

Grantee in the News: Meera Sheffrin's study on Patient Desire for Alzheimer's Predictive Testing

Jan 20

Grantee in the News: Meera Sheffrin's study on Patient Desire for Alzheimer's Predictive Testing View MoreBACK

A January 17 story in Psychiatric Times, "Do Patients Want to Know Whether Alzheimer Disease Awaits Them?" built on recently published research by 2013 and 2014 John A. Hartford Foundation’s Centers of Excellence in Geriatric Medicine and Geriatric Psychiatry Fellow Meera Sheffrin, MD.

The article explored the study “Desire for predictive testing for Alzheimer’s disease and impact on advance care planning: a cross-sectional study,” which Sheffrin co-authored and published in the December 2016 issue of the journal Alzheimer’s Research & Therapy.

As Psychiatric Times notes:

Interest in predictive testing for Alzheimer disease (AD) and advanced care planning is high among the general public, according to results of a survey-based cross-sectional study within the National Institute on Aging’s Health and Retirement Study (HRS).1 Although research on accurate prediction of AD has been ramped up, predictive testing has yet to be made available—and the question looms as to whether a person would want to live with the knowledge that AD is waiting in the wings.

...The findings confirm high public interest in predictive testing for AD. However, the proportion of respondents who already had advance directives in place was low (15%), and other studies indicate that the proportion of persons who actually establish advance directives is low compared with the proportion who agree that having them is a wise decision. The researchers suggest that their findings may be used to encourage physician-patient discussion about advanced care planning.

Read the full article here.

Dr. Meera Sheffrin is a Clinical Assistant Professor of Medicine - General Medical Disciplines at Standford University

For more on Alzheimer’s disease, read AFAR’s expert-edited InfoAging guide here.